CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
CEO: Andrew Regan. Company website
CDT Equity Inc. (CDT) trades at $0.16, down 15.04% on the day, as of Sep 20, 2026 14:59 UTC.
CDT Equity Inc. has a market capitalisation of $28,471.08, calculated from the live CDT share price and shares outstanding.
CDT trades at a trailing P/E of 0.00, from earnings per share of $1,477.50 over the last twelve months.
CDT Equity Inc. generated revenue of $2.72B over the trailing twelve months, which puts the stock at 0.00 times sales.
CDT has traded between $0.18 and $28.75 over the past 52 weeks, and the last price is 99.4% below that high.
Yes. CDT Equity Inc. keeps 8.75% of revenue as net income over the trailing twelve months.
CDT Equity Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in US .
Andrew Regan is the chief executive of CDT Equity Inc., which employs 6 people.
QFI Terminal shows CDT with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open CDT in Terminal See plans